Recombinant Human B-Cell Activating Factor (TNFSF13B/BAFF), Partial, Active
Research
Online Inquiry

Recombinant Human B-Cell Activating Factor (TNFSF13B/BAFF), Partial, Active

Cat.No: PTR-HMM-0171 Datasheet

Quantities:
- +
Product Details Related Products
Product Name Recombinant Human B-Cell Activating Factor (TNFSF13B/BAFF), Partial, Active
Catalog No. PTR-HMM-0171
Description Active human TNFSF13B fragment corresponding to residues 134-285, produced in mammalian cells with an N-terminal hFc tag. Functional interaction with BCMA and TNFRSF13C has been confirmed.
Intended Use BAFF receptor interaction studies, functional ELISA, LSPR, cytokine research, and assay development.
Principle / Technology A defined recombinant protein region is expressed and purified, then its structural integrity and target-binding function are evaluated using the listed biochemical binding assays.
Detection Method SDS-PAGE; SEC-HPLC; functional ELISA; LSPR
Sample Type Purified recombinant protein
Performance Range / Specifications >=90% by SDS-PAGE; >=90% by SEC-HPLC; calculated molecular weight 46.6 kDa; package options: 10 ug; 20 ug; 50 ug; 100 ug; 200 ug; 500 ug; 1 mg.
Sensitivity / LOD Functional ELISA showed binding to human BCMA with an EC50 of 221.3-298.6 ng/mL and to TNFRSF13C with an EC50 of 9.943-15.72 ng/mL. LSPR measured a BCMA binding affinity of 39 nM.
Specificity Binds human BCMA and TNFRSF13C.
Reaction Conditions / Protocol Briefly centrifuge the vial before opening. Reconstitute with sterile deionized water to 0.1-1.0 mg/mL. For long-term storage, add 5-50% glycerol as appropriate, divide into aliquots, and freeze.
Components / Formulation Tris- or PBS-based buffer containing 6% trehalose before lyophilization
Storage Conditions Store at -20 C or -80 C upon receipt. Aliquot before repeated use and avoid repeated freeze-thaw cycles.
Shelf Life Typical stability is 6 months for liquid material and 12 months for lyophilized material when stored at -20 C or -80 C.
Package Specifications 10 ug; 20 ug; 50 ug; 100 ug; 200 ug; 500 ug; 1 mg
Product Form Lyophilized powder
Quality Control Purity evaluated by SDS-PAGE and SEC-HPLC; endotoxin tested by LAL assay; biological activity verified by functional ELISA, LSPR.
Key Features Active Human recombinant protein; 134-285 aa expression region; Mammalian cell expression; N-terminal hFc tag; >=90% by SDS-PAGE; >=90% by SEC-HPLC; low endotoxin.
Purity >=90% by SDS-PAGE; >=90% by SEC-HPLC
Activity / Unit Definition Functional ELISA showed binding to human BCMA with an EC50 of 221.3-298.6 ng/mL and to TNFRSF13C with an EC50 of 9.943-15.72 ng/mL. LSPR measured a BCMA binding affinity of 39 nM.
Molecular Weight 46.6 kDa
Source / Origin Human protein produced in Mammalian cell.
Expiration Date / Stability Typical stability is 6 months for liquid material and 12 months for lyophilized material when stored at -20 C or -80 C.
Regulatory / Compliance For research use only; not for clinical diagnosis or treatment.
Compatibility BAFF receptor interaction studies, functional ELISA, LSPR, cytokine research, and assay development.
Recommended Buffer System Tris- or PBS-based buffer containing 6% trehalose before lyophilization
Application Notes / Precautions Avoid repeated freezing and thawing. A working aliquot may be kept at 4 C for up to one week.
Alternative Names / Synonyms B lymphocyte stimulator (BLyS); B-cell-activating factor (BAFF); Dendritic cell-derived TNF-like molecule; TNF- and APOL-related leukocyte expressed ligand 1 (TALL-1)
Lead Time 3-7 business days
Availability Status In Stock
Host Species Human
Tag Information N-terminal hFc tag
Amino Acid Sequence AVQGPEETVTQDCLQLIADSETPTIQKGSYTFVPWLLSFKRGSALEEKENKILVKETGYFFIYGQVLYTDKTYAMGHLIQRKKVHVFGDELSLVTLFRCIQNMPETLPNNSCYSAGIAKLEEGDELQLAIPRENAQISLDGDVTFFGALKLL
UniProt Accession Q9Y275
Protein Length 152 amino acids
Expression Region 134-285 aa
Endotoxin Level <1.0 EU/ug by LAL assay

For research use only, not for clinical use.

0
0

There is no product in your cart.